Other biomarkers, which are not routinely monitored (β-crosslaps and osteocalcin), were found here to be higher in patients compared to HC, and this can be attributed to their accumulation in cases of kidney failure and the time for these biomarkers to return to levels comparable to those seen in HC. Here, BGLAP is linked to kidney failure.